Intravenous ibandronate in men with osteoporosis: an open pilot study over 2 years.

@article{Lamy2003IntravenousII,
  title={Intravenous ibandronate in men with osteoporosis: an open pilot study over 2 years.},
  author={Olivier Lamy and Lorenzo Sandini and Isabelle Pache and Sandra Fatio and Jane Burnand and Peter Burckhardt},
  journal={Journal of endocrinological investigation},
  year={2003},
  volume={26 8},
  pages={728-32}
}
In the treatment of osteoporosis, the tolerance of oral bisphosphonates is often low. The high potency of ibandronate allows iv bolus injections that can be repeated every 2 to 3 months. However, the best dose and time interval of the treatment with iv ibandronate is still debated. Efficacy of 2-mg ibandronate injected every 3 months was tested in men with… CONTINUE READING